Delivery Order SPE2DB20D1110-SPE2DB25FK10D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,396.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $4,724.63 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order valued at $54,355.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets in quantities of 30 units, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and...
- The Defense Logistics Agency awarded a $13.3K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for RINVOQ ER 15 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12.3K to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $6,912.27 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $6,617.11 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, to be performed at the awardee's facility in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,761.47 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30-unit packages, with a ceiling value of $9,335. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for completion by August 28, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ...
- The Defense Logistics Agency awarded a delivery order valued at $20,253.99 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on April 25, 2025, with an ultimate completion date of April 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used primarily in the treatment of rheumatoid...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK10DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,177.04 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on April 22, 2025, with an ultimate completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed price terms and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions, representing a critical pharmaceutical supply for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, was competitively selected as a prime vendor under this strategic agreement designed to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 4/22/25 |